Anti-LITAF (KO validated) Antibody

Anti-LITAF (KO validated) Antibodyis available at Gentaur for Next week Delivery.

Description: Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene.

Immunogen Sequence:Recombinant fusion protein targeting a sequence around aa 1-161 of human LITAF

Target Alternative Name:LITAF; PIG7; SIMPLE; TP53I7

Species Reactivities:Rat,Mouse,Human

Tag Line:Rabbit polyclonal knockout validated antibody to detect the expression of LITAF in human, mouse and rat samples

Formulation:In PBS with 0.02% sodium azide, 50% glycerol, pH 7.3

Purification: Affinity purified

Application:Immunohistochemistry (IHC),Western Blotting

Positive Control:/

Application And Usages:WB 1:500 - 1:2000, IHC 1:50 - 1:200, IP 1:50 - 1:100

Handling:The antibody solution should be gently mixed before use.